-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Tianjin Food and Drug Administration and other five departments jointly issued the "Tianjin Biomedical R&D Items Import Pilot Program", piloting the implementation of the white list of biomedical enterprises (R&D institutions) imported R&D items (hereinafter referred to as the "white list") system in Tianjin
.
.
According to the principle of "optimization and innovation, efficient service, convenient customs clearance and controllable risks", the "white list" system allows biopharmaceutical enterprises (R&D institutions) to handle import declaration and release procedures
at Tianjin Customs instead of the "Customs Clearance Form for Imported Drugs" when handling the import of R&D items.
The "white list" consists of two parts: pilot enterprises and pilot items, and the pilot enterprises should have the business scale and R&D capabilities that match the pilot R&D work, ensure the scientific, reasonable and safe use of imported goods in the R&D process, and have the ability
to trace the whole process of the used items.
at Tianjin Customs instead of the "Customs Clearance Form for Imported Drugs" when handling the import of R&D items.
The "white list" consists of two parts: pilot enterprises and pilot items, and the pilot enterprises should have the business scale and R&D capabilities that match the pilot R&D work, ensure the scientific, reasonable and safe use of imported goods in the R&D process, and have the ability
to trace the whole process of the used items.
In order to promote the smooth implementation of the "white list" system, Tianjin has established a joint promotion mechanism
of the "white list" system led by the Municipal Food and Drug Administration and jointly participated by the Municipal Science and Technology Bureau, the Municipal Bureau of Commerce, Tianjin Customs and the Administrative Committee of the Pilot Free Trade Zone.
The office of the joint promotion mechanism is located in the Municipal Food and Drug Administration
.
of the "white list" system led by the Municipal Food and Drug Administration and jointly participated by the Municipal Science and Technology Bureau, the Municipal Bureau of Commerce, Tianjin Customs and the Administrative Committee of the Pilot Free Trade Zone.
The office of the joint promotion mechanism is located in the Municipal Food and Drug Administration
.
The "white list" system is driven by innovation, ensuring the smooth import of R&D materials of enterprises, effectively solving the bottleneck problem that plagues the development of the industry, and bringing more convenience
to pharmaceutical R&D innovation.
At present, a number of biomedical enterprises in Tianjin are actively preparing for application
.
(Yang Fei)
to pharmaceutical R&D innovation.
At present, a number of biomedical enterprises in Tianjin are actively preparing for application
.
(Yang Fei)
